{
    "other_tests": [
        {
            "procedure_name": "Whole Exome Sequencing (WES)",
            "date": "Not specified",
            "findings": "Heterozygous missense mutations in PROKR2 (c.253C .T; p.R85C) and WDR11 (c.1306A .G; p.I436V) were identified, with the mutations indicating a digenic mechanism.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Biochemical Analysis",
            "date": "Not specified",
            "findings": "Low thyroid hormone levels on newborn screening; serum cortisol levels were low, indicating adrenal insufficiency.",
            "changes_over_time": "Hydrocortisone replacement was initiated at 6 weeks of life due to these findings."
        },
        {
            "procedure_name": "Magnetic Resonance Imaging (MRI)",
            "date": "Not specified",
            "findings": "Demonstrated a small anterior pituitary, ectopic posterior pituitary, and a thin, interrupted pituitary stalk, consistent with PSIS.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Growth Hormone Testing",
            "date": "At age 2 9/12 years",
            "findings": "Random growth hormone level was low (0.93 ng/mL) and insulin-like growth factor-1 level was low (27 ng/mL), consistent with GH deficiency.",
            "changes_over_time": "Treatment with recombinant human growth hormone resulted in height increase to the 38th percentile and weight to the 20th percentile after approximately 15 months."
        }
    ]
}